LOS ANGELES CAPITAL MANAGEMENT LLC
Position in JAZZ — Jazz Pharmaceuticals plc
CIK 1177206
LOS ANGELES, CA
Position in JAZZ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,765,513
+$12,128,421 QoQ
Shares Held
73,725
+147.2% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#98
of 640 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. JAZZ ranks #10 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
729,635 | $219,642,024 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,938,035 | $151,689,999 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
3,958,531 | $70,541,022 | |
| 4 | INCY |
Incyte Corp
|
578,986 | $65,633,852 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130,802 | $64,973,277 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,159,457 | $63,086,055 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
98,585 | $61,471,690 | |
| 8 | RPRX |
Royalty Pharma plc
|
877,674 | $49,211,181 |
All Filings in JAZZ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,765,513 | 73,725 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,637,092 | 29,818 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $18,684,360 | 109,908 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $16,435,196 | 124,698 | Shares | Sole | 2025-10-20 | |
| 2025-03-31 | $1,053,288 | 8,484 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $592,474 | 4,811 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $624,564 | 5,606 | Shares | Sole | 2024-11-04 | |
| 2024-03-31 | $24,235,849 | 201,261 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $38,053,617 | 309,379 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $41,779,996 | 322,775 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $6,075,893 | 49,011 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $6,940,870 | 47,433 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,962,210 | 18,594 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $6,036,304 | 45,287 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $7,065,224 | 45,287 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $7,049,827 | 45,287 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $5,527,121 | 43,384 | Shares | Sole | 2022-02-03 | |
| 2021-06-30 | $1,363,031 | 7,673 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $4,043,502 | 24,600 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $4,276,280 | 25,909 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $3,535,091 | 24,792 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,760,805 | 15,958 | Shares | Sole | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||